Skip to main content
Premium Trial:

Request an Annual Quote

GenoMed Amends Deal with VC Group to Speed up Funding

NEW YORK, July 16 (GenomeWeb News) - GenoMed has amended its deal with venture capital group Pierpoint Investissements, allowing it to obtain up to $21 million in funding more quickly, the company said yesterday.


Under the original agreement from March, Pierpoint could exercise 35 million warrants over five years once GenoMed's share price reached $1. Now, Pierpoint can exercise these warrants within a 12-month period, which would result in up to $21 million for GenoMed.


If Pierpoint placed all 35 million warrants within a year, it would receive 80 million replacement warrants, but only 40 million if it placed just 20 million warrants.


Last week, GenoMed said it plans to be listed on the American Stock Exchange.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.